default author photo

Sikander Ailawadhi

affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Dose delays and treatment interruptions secondary to ocular toxicity from BMCA-directed antibody drug conjugate therapy in relapsed multiple myeloma

Number of pages: 22 Posted: 27 Aug 2025 Last Revised: 07 Feb 2026
affiliation not provided to SSRN, Mayo Clinic, Mayo Clinic, Mayo Clinic, affiliation not provided to SSRN, affiliation not provided to SSRN, Mayo Clinic, New York University (NYU) - Grossman School of Medicine, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic and Mayo Clinic - Division of Hematology
Downloads 43 (1,145,425)

Abstract:

Loading...

B-cell maturation antigen, antibody drug conjugates, Multiple myeloma, monoclonal gammopathy, keratopathy, adverse effects

2.

Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma

Number of pages: 26 Posted: 06 Nov 2024
affiliation not provided to SSRN, University of Alabama at Birmingham, affiliation not provided to SSRN, City of Hope, University of Texas at Houston - Department of Lymphoma and Myeloma, Sarah Cannon Research Institute, University of Pennsylvania - Abramson Cancer Center, University of Wisconsin-Madison, affiliation not provided to SSRN, affiliation not provided to SSRN, Winship Cancer Institute, Emory University, Medical College of Wisconsin, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 34 (1,263,436)

Abstract:

Loading...

Smoldering multiple myeloma, early relapse, CAR T-Cell therapies, triple-class refractory multiple myeloma, transplant, relapse/refractory multiple myeloma